Hungarian Pharmaceutical Market 2013

35
Hungarian Pharmaceutica l Market 2013 07.04.2014. Edit Varga Co-branding logo

description

Edit Varga. Hungarian Pharmaceutical Market 2013. 07.04.2014. Agenda. IMS Market Overview Leading Corporations Leading Therapy Classes Leading Products Promotional Activities Pharmaceutical spending Hungarian Social Insurance Public and Private funding in Pharmaceutical spending. - PowerPoint PPT Presentation

Transcript of Hungarian Pharmaceutical Market 2013

Page 1: Hungarian Pharmaceutical Market  2013

Hungarian Pharmaceutical Market 2013

07.04.2014.

Edit Varga

Co-branding logo

Page 2: Hungarian Pharmaceutical Market  2013

2

ן IMS Market Overview• Leading Corporations• Leading Therapy Classes• Leading Products• Promotional Activities

ן Pharmaceutical spending • Hungarian Social Insurance• Public and Private funding in Pharmaceutical spending

Agenda

Co-branding logo

Page 3: Hungarian Pharmaceutical Market  2013

3

Co-branding logo

Page 4: Hungarian Pharmaceutical Market  2013

4

Market size in Treatment Days

Co-branding logo

Page 5: Hungarian Pharmaceutical Market  2013

5

Co-branding logo

Page 6: Hungarian Pharmaceutical Market  2013

6

Co-branding logo

Page 7: Hungarian Pharmaceutical Market  2013

7

Co-branding logo

Page 8: Hungarian Pharmaceutical Market  2013

8

Co-branding logo

Page 9: Hungarian Pharmaceutical Market  2013

9

Co-branding logo

Page 10: Hungarian Pharmaceutical Market  2013

10

Co-branding logo

Page 11: Hungarian Pharmaceutical Market  2013

11

Co-branding logo

Page 12: Hungarian Pharmaceutical Market  2013

12

Co-branding logo

Page 13: Hungarian Pharmaceutical Market  2013

13

Co-branding logo

Page 14: Hungarian Pharmaceutical Market  2013

14

Co-branding logo

Page 15: Hungarian Pharmaceutical Market  2013

15

Co-branding logo

Page 16: Hungarian Pharmaceutical Market  2013

16

Co-branding logo

Page 17: Hungarian Pharmaceutical Market  2013

17

Co-branding logo

Page 18: Hungarian Pharmaceutical Market  2013

18

Co-branding logo

Page 19: Hungarian Pharmaceutical Market  2013

19

Co-branding logo

Page 20: Hungarian Pharmaceutical Market  2013

20

Co-branding logo

Page 21: Hungarian Pharmaceutical Market  2013

21

Co-branding logo

Page 22: Hungarian Pharmaceutical Market  2013

22

Co-branding logo

Page 23: Hungarian Pharmaceutical Market  2013

23

Co-branding logo

Page 24: Hungarian Pharmaceutical Market  2013

24

Co-branding logo

Page 25: Hungarian Pharmaceutical Market  2013

25

Pharmaceutical spending

Co-branding logo

Page 26: Hungarian Pharmaceutical Market  2013

26

Hungarian Social Insurance

Co-branding logo

900 M €

Page 27: Hungarian Pharmaceutical Market  2013

27

Public and Private funding in Pharmaceutical spending

Co-branding logo

Page 28: Hungarian Pharmaceutical Market  2013

28

Manufacturers Pay-backs to Sick Fund

Co-branding logo

Page 29: Hungarian Pharmaceutical Market  2013

29

Reimbursement Technics

Co-branding logo

Page 30: Hungarian Pharmaceutical Market  2013

30

The composition of pharmaceutical expenditure

Co-branding logo

Page 31: Hungarian Pharmaceutical Market  2013

31

Turnover of reimbursed drugs in 2012

Co-branding logo

Page 32: Hungarian Pharmaceutical Market  2013

32

Pharmaceutical Companies support to Healthcare Institutions

Co-branding logo

Page 33: Hungarian Pharmaceutical Market  2013

33

Pharmaceutical expenditures is lower almost half of 1994 expenditures

Co-branding logo

Page 34: Hungarian Pharmaceutical Market  2013

Questions?34

Page 35: Hungarian Pharmaceutical Market  2013

Thanks!